Mendel Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$676K Buy
5,263
+29
+0.6% +$3.39K 0.3% 55
2026
Q1
$630K Buy
+5,234
New +$604K 0.32% 57
2025
Q3
$430K Buy
5,126
+74
+1% +$6.09K 0.23% 70
2025
Q2
$400K Buy
5,052
+100
+2% +$7.95K 0.23% 70
2025
Q1
$445K Buy
4,952
+152
+3% +$14.2K 0.27% 67
2024
Q4
$477K Sell
4,800
-123
-2% -$12.7K 0.29% 63
2024
Q3
$559K Sell
4,923
-313
-6% -$37.2K 0.34% 58
2024
Q2
$648K Buy
5,236
+39
+0.8% +$5.02K 0.42% 52
2024
Q1
$686K Buy
5,197
+1,056
+26% +$130K 0.45% 51
2023
Q4
$451K Buy
4,141
+53
+1% +$5.5K 0.32% 62
2023
Q3
$421K Buy
4,088
+24
+0.6% +$2.59K 0.35% 60
2023
Q2
$469K Buy
4,064
+24
+0.6% +$2.73K 0.38% 56
2023
Q1
$430K Buy
4,040
+23
+0.6% +$2.48K 0.39% 48
2022
Q4
$446K Buy
4,017
+27
+0.7% +$2.76K 0.46% 44
2022
Q3
$344K Buy
3,990
+2
+0.1% +$179 0.4% 48
2022
Q2
$364K Buy
3,988
+3
+0.1% +$266 0.41% 45
2022
Q1
$327K Buy
3,985
+3
+0.1% +$237 0.31% 56
2021
Q4
$305K Buy
+3,982
New +$317K 0.28% 54

Other funds holding MRK

Mendel Capital Management's MRK Position: Q2 2026 in Review

Mendel Capital Management increased its Merck (MRK) stake by 0.55% in Q2 2026, buying an estimated $3.39K and bringing the position to 5,263 shares worth $676K. The position accounts for 0.3% of the portfolio, ranked #55.

Mendel Capital Management first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. The position peaked at $686K in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Mendel Capital Management held 5,263 shares of Merck worth $676K as of Q2 2026.
  • Mendel Capital Management bought 29 Merck shares in Q2 2026, an estimated $3.39K.
  • Merck made up 0.3% of Mendel Capital Management's portfolio in Q2 2026, its #55 holding.
  • Mendel Capital Management first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
  • Mendel Capital Management's Merck position peaked at $686K in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Mendel Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.